Pulmonary Function Tests (PFTs) are essential diagnostic tools in the field of respiratory medicine, providing a wealth of information about lung function. However, their interpretation can be complex. This article aims to provide a comprehensive guide to interpreting PFTs for healthcare professionals.
Spirometry is the most common of the PFTs. It measures the volume and speed of air that can be inhaled and exhaled. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), and their ratio (FEV1/FVC). A reduced FEV1/FVC ratio indicates obstructive lung disease, while a reduced FVC with a normal FEV1/FVC ratio suggests restrictive lung disease.
These tests measure the lungs' ability to transfer gas from inhaled air to the red blood cells. The most common is the Diffusing Capacity for Carbon Monoxide (DLCO). Reduced DLCO may indicate conditions such as emphysema or pulmonary fibrosis.
These tests measure the total volume of air the lungs can hold (Total Lung Capacity, TLC), the volume remaining at the end of a normal exhalation (Functional Residual Capacity, FRC), and the volume of air remaining after a maximal exhalation (Residual Volume, RV). Increased RV and FRC with a normal TLC suggest air trapping, common in obstructive diseases.
These tests assess airway hyperresponsiveness, a hallmark of asthma. A significant decrease in FEV1 following exposure to a bronchoconstrictor indicates a positive test.
Interpreting PFTs is a skill that requires understanding of the tests' physiological basis and clinical implications. This guide provides a foundation for healthcare professionals to accurately interpret these tests, ultimately improving patient care in respiratory medicine. Continued education and practice are key to mastering this complex yet essential skill.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation